We are live on ! Find out more
GF

Gates Foundation Portfolio holdings

AUM $43.5M
1-Year Est. Return 14.19%
This Fund
S&P 500
This Quarter Est. Return
-9.02%
1 Year Est. Return
+14.19%
3 Year Est. Return
-58.08%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$40.2M
AUM Growth
-$43.9M
Cap. Flow
-$37.7M
Cap. Flow %
-93.78%
Top 10 Hldgs %
100%
Holding
8
New
–
Increased
–
Reduced
–
Closed
3

Top Buys

No buys this quarter

Top Sells

Rank Stock Value
1
IMCR icon
Immunocore
IMCR
+$37.5M
2
LMDX
LumiraDx Limited Common Shares
LMDX
+$143K
3
BCEL
Atreca, Inc. Class A Common Stock
BCEL
+$73K

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
VIR icon
1
Vir Biotechnology
VIR
$1.58B
$13.9M 34.5%
1,559,142
– –
BNTX icon
2
BioNTech
BNTX
$23.3B
$11.9M 29.71%
148,674
– –
EXAI
3
DELISTED
Exscientia Plc American Depositary Shares
EXAI
$8.11M 20.17%
1,590,909
– –
CVAC
4
DELISTED
CureVac
CVAC
$5.43M 13.51%
1,597,637
– –
BFLY icon
5
Butterfly Network
BFLY
$1.73B
$849K 2.11%
1,011,003
– –
IMCR icon
6
Immunocore
IMCR
$1.81B
– –
-576,923
Closed -$37.5M
BCEL
7
DELISTED
Atreca, Inc. Class A Common Stock
BCEL
– –
-912,642
Closed -$73K
LMDX
8
DELISTED
LumiraDx Limited Common Shares
LMDX
– –
-14,285,714
Closed -$143K

Similar funds

NV
Northpond Ventures Bethesda, Maryland $43.7M AUM 27.27% 1-Year Est. Return
IV
Industry Ventures San Francisco, California $43.2M AUM 36.57% 1-Year Est. Return
RCM
Riverwood Capital Management Menlo Park, California $43.2M AUM 24% 1-Year Est. Return
EPWM
Essex Private Wealth Management Topsfield, Massachusetts $42.5M AUM 29.61% 1-Year Est. Return
SCMC
Serent Capital Management Company San Francisco, California $44.9M AUM 20.57% 1-Year Est. Return
GF
Genesis Fortune Grand Cayman, Cayman Islands $41.8M AUM 76.19% 1-Year Est. Return
AS
AM Squared Hong Kong $45.2M AUM 4.27% 1-Year Est. Return
BCP
Berylson Capital Partners Boston, Massachusetts $41.2M AUM 0.19% 1-Year Est. Return

Gates Foundation's Q2 2024 Portfolio in Review

As of Q2 2024, Gates Foundation held 8 positions worth $40.2M, down 52% from $84.1M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Gates Foundation withdrew a net $37.7M in Q2 2024, closing 3 positions. Its most notable exit was Immunocore, an estimated $37.5M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • Gates Foundation fully exited Immunocore in Q2 2024, selling an estimated $37.5M.
  • Gates Foundation's ten largest holdings make up 100% of its $40.2M portfolio in Q2 2024.
  • Gates Foundation opened 0 new positions and closed 3 in Q2 2024.
  • Gates Foundation's portfolio value fell 52% quarter-over-quarter to $40.2M.

Based on Gates Foundation's 13F filing for Q2 2024, filed 14 Aug 2024.